| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |